<p>Glass Lewis, a leading proxy advisory firm, has reaffirmed its recommendation that shareholders vote against the proposed acquisition of STAAR Surgical Company by Alcon Inc. The firm cited concerns over the STAAR board’s procedural credibility, stating that the process leading up to the revised offer lacked transparency and failed to maximize value for shareholders. Glass Lewis also criticized the structure of the go-shop process, suggesting it favored Alcon and was overseen by a conflicted board and advisors. The advisory firm concluded that the increased offer from Alcon does not clearly reflect STAAR’s full market value. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20251212697461) on December 12, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

STAA

<p>Glass Lewis advises STAAR Surgical shareholders to reject Alcon's acquisition offer, citing concerns over procedural transparency and value maximization. The advisory firm criticizes the go-shop process as favoring Alcon and questions the board's credibility. Glass Lewis believes the offer does not reflect STAAR's full market value.</p>

Glass Lewis Recommends STAAR Surgical Shareholders Reject Alcon Acquisition